Advertisement

Topics

Shire’s SHP647 bags another orphan badge

03:04 EST 15 Feb 2018 | PharmaTimes

US regulators have awarded orphan drug status to Shire's investigational therapy, SHP647, for the treatment of paediatric patients with moderately to severely active Crohn's disease.

Original Article: Shire’s SHP647 bags another orphan badge

NEXT ARTICLE

More From BioPortfolio on "Shire’s SHP647 bags another orphan badge"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...